Shinsuke Hisaka Selected Research

Anti-Allergic Agents (Antiallergic Agents)

1/2022	Orengedokuto exerts anti-allergic effects via inhibition of effector T cell activation in a murine model of contact hypersensitivity.
1/2022	Juzentaihoto Exerts Anti-Allergic Effects by Inhibiting Effector T-Cell Activation and Inducing and/or Activating Regulatory T Cells in a Murine Model of Contact Hypersensitivity.
9/2021	Effect of glucoglycyrrhizin on IgE-mediated immediate hypersensitivity in mice.
3/2020	Evaluation of the safety and efficacy of Glycyrrhiza uralensis root extracts produced using artificial hydroponic and artificial hydroponic-field hybrid cultivation systems III: anti-allergic effects of hot water extracts on IgE-mediated immediate hypersensitivity in mice.
3/2020	Effect of hot water extract of a glycyrrhizin-deficient strain of Glycyrrhiza uralensis on contact hypersensitivity in mice.
6/2019	Mutagenetic and anti-allergic studies for evaluation of extracts of Coptis Rhizome produced by an artificial hydroponic system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinsuke Hisaka Research Topics

Disease

5	Inflammation (Inflammations) 01/2022 - 03/2010
4	Contact Dermatitis (Eczema, Contact) 01/2022 - 06/2019
2	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2022
2	Skin Diseases (Skin Disease) 01/2022 - 01/2022
2	Immediate Hypersensitivity 09/2021 - 03/2020
2	Liddle Syndrome 09/2019 - 10/2017
2	Neuroblastoma 05/2018 - 07/2008
1	Hypertension (High Blood Pressure) 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022
1	Parkinson Disease (Parkinson's Disease) 05/2018
1	Drug-Related Side Effects and Adverse Reactions 10/2017
1	Disease Progression 01/2016
1	Acute Liver Failure (Fulminant Hepatic Failure) 12/2014
1	Rheumatic Diseases (Rheumatism) 01/2014
1	Allergic Contact Dermatitis 01/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014
1	Atherosclerosis 01/2014
1	Body Weight (Weight, Body) 02/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2008

Drug/Important Bio-Agent (IBA)

6	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2022 - 06/2019
3	Glycyrrhizic Acid (Glycyrrhizin)IBA 03/2020 - 10/2017
3	LipidsIBA 05/2018 - 07/2008
2	Immunoglobulin E (IgE)IBA 09/2021 - 03/2020
2	Docosahexaenoic AcidsIBA 05/2018 - 07/2008
1	juzentaihotoIBA 01/2022
1	GlycosidesIBA 09/2021
1	Glycyrrhetinic Acid (Po 12)IBA 09/2021
1	Pharmaceutical PreparationsIBA 03/2020
1	SynucleinsIBA 05/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2018
1	Lysine (L-Lysine)FDA Link 05/2018
1	Indicators and Reagents (Reagents)IBA 05/2018
1	hypobromous acidIBA 01/2016
1	Amino Acids FDA Link 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	ErgothioneineIBA 01/2016
1	Hypochlorous Acid (Hypochlorite)IBA 01/2016
1	Peroxidase (Myeloperoxidase)IBA 01/2016
1	LipopolysaccharidesIBA 12/2014
1	Farnesyltranstransferase (Farnesyltransferase)IBA 12/2014
1	tipifarnib (R115777)IBA 12/2014
1	GalactosamineIBA 12/2014
1	Cysteine (L-Cysteine)FDA Link 12/2014
1	Lipid PeroxidesIBA 01/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014
1	oxidized low density lipoproteinIBA 01/2014
1	Biological ProductsIBA 01/2014
1	AllergensIBA 01/2014
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2014
1	LigandsIBA 01/2014
1	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2012
1	Biomarkers (Surrogate Marker)IBA 03/2010
1	Linoleic Acid (Linoleate)IBA 07/2008
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 07/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2008
1	Arachidonic Acid (Vitamin F)IBA 07/2008

Therapy/Procedure

3	Kampo Medicine (Kampo) 01/2022 - 10/2017
1	Baths 01/2014
1	Intraperitoneal Injections 02/2012